Address
Email address
https://euroapteek.eeE-apteek | Euroapteek.eeEuroapteek e-apteegist saate osta kosmeetikatooteid, toidulisandeid ja käsimüügiravimeid. Lisaks saate e-apteegist oste sooritada igal pool, Teile sobival ajal.
Name
OÜ PharmaFourteen
Registry code
14915677
VAT number
EE102233856
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
19.02.2020 (4)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
47731 - Dispensing chemist in specialised stores
6 142 509 €
2 804 €
0%
3 979 €
(estimate is approximate)
-293 792 €
3
Submitted
No tax arrears
-1%
0%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Omanikukonto: PIRET RAAD 15.08.1975 (49) | 100% - 2 500.00 EUR | Board member | Direct ownership | |
| Osaühing EUROAPTEEK 11036389 | - | - | - | Founder |
| 2020 30.06.2021 | 2021 20.06.2022 | 2022 19.06.2023 | 2023 21.06.2024 | |
|---|---|---|---|---|
| Total Revenue | 3 340 561 € | 5 046 991 € | 5 543 790 € | 6 142 509 € |
| Net profit (loss) for the period | -354 398 € | 127 838 € | -72 537 € | 2 804 € |
| Profit Margin | -11% | 3% | -1% | 0% |
| Current Assets | 746 839 € | 785 648 € | 1 166 568 € | 973 013 € |
| Fixed Assets | 1 547 773 € | 1 380 413 € | 1 213 052 € | 830 293 € |
| Total Assets | 2 294 612 € | 2 166 061 € | 2 379 620 € | 1 803 306 € |
| Current Liabilities | 2 646 510 € | 2 390 121 € | 2 676 216 € | 2 097 098 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | -351 898 € | -224 060 € | -296 596 € | -293 792 € |
| Employees | 2 | 1 | 3 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 1 777 027.98 € | 8 142.42 € | 19 695.23 € | 7 |
| 2023 Q4 | 1 673 403.79 € | 6 113.64 € | 17 432.4 € | 9 |
| 2023 Q3 | 1 422 623.09 € | 4 180.3 € | 21 147.33 € | 8 |
| 2023 Q2 | 1 471 350.87 € | 7 322.43 € | 19 067.37 € | 8 |
| 2023 Q1 | 1 506 012.98 € | 8 570.42 € | 19 031.22 € | 8 |
| 2022 Q4 | 1 464 395.93 € | 7 156.12 € | 18 304.83 € | 8 |
| 2022 Q3 | 1 183 225.54 € | 7 364.9 € | 20 546.64 € | 8 |
| 2022 Q2 | 1 429 395.66 € | - | 7 065.09 € | 3 |
| 2022 Q1 | 1 379 404.85 € | - | 6 145.57 € | 1 |
| 2021 Q4 | 1 422 958.75 € | 7 698.93 € | 6 580.07 € | 1 |
| 2021 Q3 | 1 173 437.38 € | - | 6 360.33 € | 1 |
| 2021 Q2 | 1 246 087.08 € | 9 081.81 € | 5 568.41 € | 1 |
| 2021 Q1 | 1 171 289.78 € | 4 766.94 € | 5 168.15 € | 1 |
| 2020 Q4 | 1 202 446.41 € | 7 906.08 € | 8 474.86 € | 1 |
| 2020 Q3 | 1 017 047.18 € | 10 887.85 € | 11 659.53 € | 3 |
| 2020 Q2 | 628 207.37 € | - | - | - |
| 2020 Q1 | - | - | - | - |
